Ophthalmology

The acquisition includes clinical stage anti-IGF-1R monoclonal antibody VRDN-001, which is intended for treatment of thyroid eye disease

Vanda Pharmaceuticals gains FDA approval on their IND for VSJ-110 to treat allergic conjunctivitis

Astrocytes could play a critical role in nerve death in neurodegenerative diseases

San Diego Academy of Regenerative Therapies publishes article about first-in-human clinical trial using adipose-derived SVF to treat post-COVID-19 patients suffering lung damage

ADVM-022 demonstrates efficacy, durability in OPTIC trial in wet AMD

ProQR offers upbeat interim analysis in Phase 1/2 trial of QR-421a for Usher Syndrome

Ocugen’s gene therapy candidate shows potential in five different models of retinitis pigmentosa

Two new cell models for ocular drug discovery could reduce the need for animal testing

Adverum’s wet AMD candidate helps maintain vision in Phase 1 trial

Clearside announces option exercise by REGENXBIO for gene therapy delivery tech